Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Buske

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Hematology/Oncology Clinics of North America|September 8, 2018
Alkylating Agents in the Treatment of Waldenström MacroglobulinemiaChristian Buske
Idrugs : the Investigational Drugs Journal|May 1, 2010
Hematologic malignancies-sixth European congress. 26-28 February 2010, Cannes, France Christian Buske
Cell Stem Cell|August 3, 2019
Cutting Off Leukemogenesis: Hydra-like Plasticity of Mature Leukemic CellsShiva Bamezai, Christian Buske
Expert Review of Hematology|November 15, 2011
Stem cells and beyond: report on the 40th Annual Scientific Meeting of the International Society of Experimental HematologyArefeh Rouhi, Christian Buske
Deutsche Medizinische Wochenschrift (1946)|February 4, 2016
[New developments in Waldenström's macroglobulinemia]Alexander Grunenberg, Christian Buske
Future Oncology (London, England)|June 12, 2019
Rituximab and ibrutinib in the treatment of Waldenström's macroglobulinemiaAlexander Grunenberg, Christian Buske
Deutsches Arzteblatt International|November 25, 2017
Monoclonal IgM Gammopathy and Waldenström's MacroglobulinemiaAlexander Grunenberg, Christian Buske
Leukemia Research|June 6, 2006
Rituximab maintenance therapy in indolent NHL: a clinical reviewChristian Buske, Wolfgang Hiddemann
Cancer Treatment Reviews|March 12, 2024
How to manage waldenström's macroglobulinemia in 2024Alexander Grunenberg, Christian Buske
Cell Cycle (Georgetown, Tex.)|March 3, 2007
Lymphoid progenitors as candidate cancer stem cells in AML: new perspectivesAniruddha J Deshpande, Christian Buske
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Hematology/Oncology Clinics of North America|September 8, 2018
Alkylating Agents in the Treatment of Waldenström MacroglobulinemiaChristian Buske
Idrugs : the Investigational Drugs Journal|May 1, 2010
Hematologic malignancies-sixth European congress. 26-28 February 2010, Cannes, France Christian Buske
Cell Stem Cell|August 3, 2019
Cutting Off Leukemogenesis: Hydra-like Plasticity of Mature Leukemic CellsShiva Bamezai, Christian Buske
Expert Review of Hematology|November 15, 2011
Stem cells and beyond: report on the 40th Annual Scientific Meeting of the International Society of Experimental HematologyArefeh Rouhi, Christian Buske
Deutsche Medizinische Wochenschrift (1946)|February 4, 2016
[New developments in Waldenström's macroglobulinemia]Alexander Grunenberg, Christian Buske
Future Oncology (London, England)|June 12, 2019
Rituximab and ibrutinib in the treatment of Waldenström's macroglobulinemiaAlexander Grunenberg, Christian Buske
Deutsches Arzteblatt International|November 25, 2017
Monoclonal IgM Gammopathy and Waldenström's MacroglobulinemiaAlexander Grunenberg, Christian Buske
Leukemia Research|June 6, 2006
Rituximab maintenance therapy in indolent NHL: a clinical reviewChristian Buske, Wolfgang Hiddemann
Cancer Treatment Reviews|March 12, 2024
How to manage waldenström's macroglobulinemia in 2024Alexander Grunenberg, Christian Buske
Cell Cycle (Georgetown, Tex.)|March 3, 2007
Lymphoid progenitors as candidate cancer stem cells in AML: new perspectivesAniruddha J Deshpande, Christian Buske
Pageof 15